KRAS and neoplasm: Bryant, Kirsten L. et al. have demonstrated that oncogenic KRAS plays a central role in regulating tumor metabolism, orchestrating diverse metabolic changes such as enhanced glucose uptake, selective channeling of glucose intermediates, reprogrammed glutamine metabolism, increased autophagy, and macropinocytosis (Bryant et al., 2014).